HY-11

a synthetic vitamin D3 analog with antileukemic effect and low potential to cause hypercalcemia; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Myeloid Leukemia (Leukemia, Myelocytic) 02/01/2008 - "In particular, HY-11 significantly increased the survival of mice that had myeloid leukemia without producing hypercalcemia."
2.	Hypercalcemia (Milk Alkali Syndrome) 02/01/2008 - "HY-11 inhibited the growth of WEHI-3BD+ mouse leukemic cells in vitro, and syngeneic BALB/c mice that received WEHI-3BD+ mouse leukemic cells and HY-11 had a significantly longer survival without producing hypercalcemia compared to control group. " 02/01/2008 - "In particular, HY-11 significantly increased the survival of mice that had myeloid leukemia without producing hypercalcemia." 02/01/2008 - "Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia."

1.	Cholecalciferol (Vitamin D3)